Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AAP Presses FDA To Eliminate OTC Pediatric Combination Products

This article was originally published in The Tan Sheet

Executive Summary

The American Academy of Pediatrics wants FDA to eliminate OTC combination pediatric cough/cold products.

You may also be interested in...



Despite EC Switch Denial, Attorneys See Value In Non-Sponsor Petitions

Despite EC Switch Denial, Attorneys See Value In Non-Sponsor Petitions

Pediatric Acetaminophen Panel Debates Execution Of Dosing Changes

Pediatric OTC acetaminophen product labels should include directions for children under 2 years and as young as 6 months and instructions for dosing by weight, a panel of advisors told FDA.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS105076

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel